drugset / Trial / NCT00965874

Low Versus High Dose Magnesium Sulfate in the Early Management of Rapid Atrial Fibrillation

NCT00965874

Phase 3 Completed 450 enrolled University of Monastir
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Objective: To assess the efficacy and the safety of high (9g) and low dose (4.5g) of MgS in the immediate treatment of rapid AF.

Timeline

Start
2009-11
Primary completion
2014-04
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 4.5 g Other
Subject Magnesium Sulfate Other / unclassified 9 g Other

Indications